Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Rheumatology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Rheumatology Other
    Rilonacept Approved in the EU for Cryopyrin-Associated Periodic Syndromes - (DGNews)
    Canakinumab Gives Faster, Greater Pain Relief in Refractory Gout Patients: Presented at ACR/ARHP - (DGDispatch)
    Previous Urate-Lowering Therapy Plus Febuxostat Lowers Urate Levels, Number of Flares in Patients With Gout: Presented at ACR/ARHP - (DGDispatch)
    Low-Dose Colchicine Eases Pain Due to Acute Gout Flare: Presented at ACR/ARHP - (DGDispatch)
    Combination Therapy With Zoledronic Acid/Teriparatide Has Beneficial Effects on Bone Mass Density: Presented at ACR/ARHP - (DGDispatch)

    News archive

     Recent webcasts/CME - Rheumatology Other
    Biologics and Infections: Common and Rare

    Webcasts/CME archive

     Recent cases - Rheumatology Other
      Rectal Mucosal Prolapse Syndrome as an Unusual Gastrointestinal Manifestation of Sjogren's Syndrome: A Case Report
      HELLP Syndrome, Multiple Liver Infarctions, and Intrauterine Fetal Death in a Patient with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
      Nasal Septal Perforation in a Patient with Takayasu's Arteritis; a Rare Association
      Nummular Keratopathy in a Patient with Hyper-IgD Syndrome
      Congenital Heart Block Associated with Sjogren Syndrome: Case Report

      Cases archive
        




      my personal edition > rheumatology other > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Measure Aids Chronic Fatigue Syndrome Assessment

      A DGReview of :"Hemodynamics instability score in chronic fatigue syndrome and in non-chronic fatigue syndrome."
      Seminars in Arthritis and Rheumatism

      01/23/2003
      By Anne MacLennan


      A particular and quantifiable abnormality in the cardiovascular reactivity of most patients with chronic fatigue syndrome provides an new objective tool for assessing this disorder, suggest researchers in Israel.

      Using a method they developed of giving numerical expression to degree of blood pressure and heart rate lability, the investigators had previously found this 'haemodynamic instability score' (HIS) in CFS patients differs significantly from that in healthy subjects.

      In the current investigation, they found the large majority of CFS patients exhibit an abnormality which is characterised by HIS values >-0.98. Thus, HIS >-0.98 lends objective criteria to the assessment of CFS, report Dr J E Naschitz and colleagues from the Bnai Zion Medical Center and the Technion-Israel Institute of Technology, Haifa, Israel.

      This study compared the HIS in CFS, non-CFS chronic fatigue and patients with recurrent syncope.

      Twenty patients with CFS, 24 with non-CFS chronic fatigue, 44 with syncope of unknown cause and 21 age and sex-matched healthy controls were all evaluated with a standardised head-up tilt test (HUTT).

      Abnormal reactions (endpoints) on HUTT were classified 'clinical outcomes' (cardioinhibitory or vasodepressor reaction, orthostatic hypotension, postural tachycardia syndrome) and 'HIS endpoint', ie HIS >-0.98.

      Highest incidence of endpoints was noted in patients with CFS (79%), followed by patients with syncope of unknown cause (46%), non-CFS chronic fatigue (35%) and healthy controls (14%).

      Presyncope or syncope during tilt occurred in 38% of CFS patients, 21% of non-CFS chronic fatigue patients and 43% of those with recurrent syncope.

      Average HIS values were: CFS = +2.02 (SD 4.07), non-CFS chronic fatigue = -2.89 (SD 3.64), syncope = -3.2 (SD 3.0) and healthy = -2.48 (4.07).

      Odds ratios for CFS patients to have HIS >-0.98 was 8.8 compared with non-CFS chronic fatigue patients, 14.6 compared with recurrent syncope patients and 34.8 compared with healthy controls.

      The investigators point out the cardiovascular reactivity in patients with CFS has certain features in common with the reactivity in patients with recurrent syncope or non-CFS chronic fatigue, such as the frequent occurrence of vasodepressor reaction, cardioinhibitory reaction, and postural tachycardia syndrome.

      However, apart from these shared responses, most patients with CFS exhibit this particular abnormality, which is characterised by HIS values >-0.98, lending objective criteria to CFS assessment, these authors conclude.
      Semin Arthritis Rheum 2002 Dec;32(3):141-8. "Hemodynamics instability score in chronic fatigue syndrome and in non-chronic fatigue syndrome."

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send